Aravive, Inc.·4

Jan 25, 4:06 PM ET

McIntyre Gail Frances 4

4 · Aravive, Inc. · Filed Jan 25, 2022

Insider Transaction Report

Form 4
Period: 2022-01-24
McIntyre Gail Frances
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to buy)

    2022-01-24+425,000425,000 total
    Exercise: $2.18From: 2022-02-24Exp: 2032-01-24Common Stock (425,000 underlying)
Footnotes (1)
  • [F1]These options vest pro rata on a monthly basis over four (4) years commencing on February 24, 2022, the one-month anniversary of the grant date.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4